In 2023, Germany topped labor costs in the European pharmaceutical sector at 11.46 billion euros, significantly ahead of Italy and France. Austria, Netherlands, and Baltic states showed far lower values, indicating economic scalability and labor cost advantages.
From 2022 to 2023, Germany, Belgium, Austria, and Slovenia had substantial growth ranging between 3% and 3.75%. Conversely, Dutch growth was minimal at just 0.34%. Over five years, all countries experienced varying labor cost growth, showcasing evolving market dynamics and economic landscapes.
Future trends highlight potential shifts in labor cost distribution as countries optimize for post-pandemic recovery and competitive manufacturing advancements. Monitoring automation, policy changes, and cross-border collaborations will be crucial.
Top countries in Labour Costs in Basic Pharmaceutical Products and Pharmaceutical Preparations by Country
| # | 10 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 11,460 | 2023 | +2.27% | +3.75% | View data |
| 2 | 2 Italy | 4,840 | 2023 | +1.18% | +1.61% | View data |
| 3 | 3 France | 4,490 | 2023 | +0.81% | +0.87% | View data |
| 4 | 4 Belgium | 3,290 | 2023 | +2.72% | +3.14% | View data |
| 5 | 5 Spain | 2,350 | 2023 | +0.9% | +1.08% | View data |
| 6 | 6 Austria | 1,350 | 2023 | +2.78% | +2.87% | View data |
| 7 | 7 Netherlands | 1,010 | 2023 | +0.5% | +0.34% | View data |
| 8 | 8 Slovenia | 529.1 | 2023 | +2.78% | +2.56% | View data |
| 9 | 9 Greece | 403.05 | 2023 | +1.01% | +1.75% | View data |
| 10 | 10 Finland | 309 | 2023 | +1.64% | +2.14% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
